Kwangdong Phar (009290) - Total Assets
Based on the latest financial reports, Kwangdong Phar (009290) holds total assets worth ₩1.32 Trillion KRW (≈ $894.77 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 009290 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Kwangdong Phar - Total Assets Trend (2011–2025)
This chart illustrates how Kwangdong Phar's total assets have evolved over time, based on quarterly financial data. See Kwangdong Phar (009290) net assets for net asset value and shareholders' equity analysis.
Kwangdong Phar - Asset Composition Analysis
Current Asset Composition (December 2025)
Kwangdong Phar's total assets of ₩1.32 Trillion consist of 54.4% current assets and 45.7% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 10.7% |
| Accounts Receivable | ₩268.90 Billion | 20.4% |
| Inventory | ₩203.57 Billion | 15.4% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩21.28 Billion | 1.6% |
| Goodwill | ₩27.88 Billion | 2.1% |
Asset Composition Trend (2011–2025)
This chart illustrates how Kwangdong Phar's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Kwangdong Phar (009290) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kwangdong Phar's current assets represent 54.4% of total assets in 2025, an increase from 0.0% in 2011.
- Cash Position: Cash and equivalents constituted 10.7% of total assets in 2025, up from 6.1% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 20.4% of total assets.
Kwangdong Phar Competitors by Total Assets
Key competitors of Kwangdong Phar based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Nestle S.A.
SW:NESN
|
Switzerland | CHF127.15 Billion |
|
Unibel S.A
PA:UNBL
|
France | €4.09 Billion |
|
Sanquan Food Co Ltd
SHE:002216
|
China | CN¥7.57 Billion |
|
Xiamen Kingdomway Group Co
SHE:002626
|
China | CN¥8.38 Billion |
|
Grupo Herdez S.A.B. de C.V
MX:HERDEZ
|
Mexico | MX$35.95 Billion |
|
Bellring Brands LLC
NYSE:BRBR
|
USA | $1.03 Billion |
|
Beijing Sanyuan Foods Co Ltd
SHG:600429
|
China | CN¥8.86 Billion |
|
Kri-Kri Milk Industry S.A
AT:KRI
|
Greece | €219.80 Million |
Kwangdong Phar - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.36 | 1.56 | 1.83 |
| Quick Ratio | 0.98 | 1.09 | 1.31 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩191.71 Billion | ₩257.81 Billion | ₩257.73 Billion |
Kwangdong Phar - Advanced Valuation Insights
This section examines the relationship between Kwangdong Phar's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.45 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 12.8% |
| Total Assets | ₩1.32 Trillion |
| Market Capitalization | $150.30 Million USD |
Valuation Analysis
Below Book Valuation: The market values Kwangdong Phar's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Kwangdong Phar's assets grew by 12.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Kwangdong Phar (2011–2025)
The table below shows the annual total assets of Kwangdong Phar from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩1.32 Trillion ≈ $894.77 Million |
+12.82% |
| 2024-12-31 | ₩1.17 Trillion ≈ $793.08 Million |
+8.55% |
| 2023-12-31 | ₩1.08 Trillion ≈ $730.59 Million |
+15.67% |
| 2022-12-31 | ₩932.02 Billion ≈ $631.62 Million |
+5.45% |
| 2021-12-31 | ₩883.85 Billion ≈ $598.97 Million |
+6.40% |
| 2020-12-31 | ₩830.64 Billion ≈ $562.92 Million |
+4.78% |
| 2019-12-31 | ₩792.78 Billion ≈ $537.25 Million |
+8.29% |
| 2018-12-31 | ₩732.06 Billion ≈ $496.10 Million |
+1.29% |
| 2017-12-31 | ₩722.70 Billion ≈ $489.76 Million |
+6.31% |
| 2016-12-31 | ₩679.78 Billion ≈ $460.68 Million |
+2.41% |
| 2015-12-31 | ₩663.79 Billion ≈ $449.84 Million |
+50.00% |
| 2014-12-31 | ₩442.53 Billion ≈ $299.90 Million |
+3.96% |
| 2013-12-31 | ₩425.68 Billion ≈ $288.47 Million |
+9.31% |
| 2012-12-31 | ₩389.43 Billion ≈ $263.91 Million |
+21.06% |
| 2011-12-31 | ₩321.68 Billion ≈ $218.00 Million |
-- |
About Kwangdong Phar
Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti… Read more